Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cancer patients aged over 18 years; 2. With a predicted survival period exceeding 3 months; 3. Requiring infusion of irritant or cytotoxic agents such as chemotherapy drugs or targeted therapies; 4. Requiring prolonged infusion of hypertonic solutions including parenteral nutrition; 5. Requiring continuous or intermittent intravenous infusion therapy; 6. Requiring repeated transfusion of blood products; 7. Requiring frequent blood sampling for monitoring purposes.
Exclusion criteria
Exclusion criteria: 1. Patients with uncontrolled local infection or concurrent acute systemic infection that cannot be effectively managed; 2. Venous return disorders such as superior vena cava syndrome or thrombosis at the puncture site; 3. Patients who have undergone right breast cancer surgery or are scheduled for right chest surgery; 4. Head and neck or pulmonary tumours where the radiotherapy field overlaps the intended port placement site in the right chest; 5. Severe coagulation disorders (prothrombin time or activated partial thromboplastin time prolonged by more than twofold, INR > 2.0, platelet count below 30 × 10?/L); 6. Known allergy to port materials such as silicone, polyurethane, or titanium.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First-attempt puncture success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of perioperative complications;Postoperative complication incidence rate;Surgery time;Tube length;comfort level;Tube retention time; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Soochow University